atorvastatin has been researched along with Non-ST Elevated Myocardial Infarction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abusoglu, G; Abusoglu, S; Erdem, K; Eryavuz Onmaz, D; Sivrikaya, A; Unlu, A; Yaglioglu, H | 1 |
| Dardiri, M; Samir, A; Shehata, M | 1 |
| Aquino, M; Baber, U; Barman, N; Camaj, A; Chandrasekhar, J; Claessen, B; Dangas, G; Faggioni, M; Farhan, S; Guedeney, P; Kalkman, DN; Kini, A; Kovacic, JC; Mehran, R; Moreno, P; Shah, S; Sharma, S; Sorrentino, S; Sweeny, J; Vijay, P; Vogel, B | 1 |
| Huynh, GA; Lee, AJ | 1 |
1 review(s) available for atorvastatin and Non-ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
High-Intensity Atorvastatin-Induced Rhabdomyolysis in an Elderly Patient With NSTEMI: A Case Report and Review of the Literature.
Topics: Aged, 80 and over; Atorvastatin; Dose-Response Relationship, Drug; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Non-ST Elevated Myocardial Infarction; Rhabdomyolysis | 2017 |
1 trial(s) available for atorvastatin and Non-ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients.
Topics: Atorvastatin; Biomarkers; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Non-ST Elevated Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Stroke Volume | 2017 |
2 other study(ies) available for atorvastatin and Non-ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
New steps in acute coronary syndrome and antihyperlipidemic treatment: Determination of statins and metabolites by liquid chromatography tandem mass spectrometry.
Topics: Acute Coronary Syndrome; Atorvastatin; Chromatography, Liquid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Non-ST Elevated Myocardial Infarction; Rosuvastatin Calcium; ST Elevation Myocardial Infarction; Tandem Mass Spectrometry | 2022 |
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Practice Guidelines as Topic; Prospective Studies; Registries; Rosuvastatin Calcium; Secondary Prevention; Simvastatin; ST Elevation Myocardial Infarction; Tertiary Care Centers; Time Factors | 2019 |